These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of CYP enzymes in cocaine-induced liver damage. Pasanen M; Pellinen P; Stenbäck F; Juvonen RO; Raunio H; Pelkonen O Arch Toxicol; 1995; 69(5):287-90. PubMed ID: 7654131 [TBL] [Abstract][Full Text] [Related]
9. [Cocaine abuse--with special reference to cerebrovascular complications]. Lalouschek W; Schnider P; Aull S; Uhl F; Zeiler K; Deecke L; Lesch OM Wien Klin Wochenschr; 1995; 107(17):516-21. PubMed ID: 7483634 [TBL] [Abstract][Full Text] [Related]
10. Liver abnormalities in drug and substance abusers. Pateria P; de Boer B; MacQuillan G Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):577-96. PubMed ID: 24090944 [TBL] [Abstract][Full Text] [Related]
16. Nonocular manifestations of parenteral drug abuse. Michelson JB; Robin HS; Nozik RA Surv Ophthalmol; 1986; 30(5):314-20. PubMed ID: 3520910 [TBL] [Abstract][Full Text] [Related]
17. [Liver lesions in drug addicted adolescents]. Brunner VH; Kroiss A; Grabner G; Ranefeld J Acta Med Austriaca; 1974; 2(1):48-54. PubMed ID: 4478125 [No Abstract] [Full Text] [Related]
18. Involvement of FAD-containing monooxygenase in cocaine-induced hepatotoxicity. Kloss MW; Cavagnaro J; Rosen GM; Rauckman EJ Toxicol Appl Pharmacol; 1982 Jun; 64(1):88-93. PubMed ID: 7112588 [No Abstract] [Full Text] [Related]
19. Drugs of abuse and addiction: A slippery slope toward liver injury. Roy DN; Goswami R Chem Biol Interact; 2016 Aug; 255():92-105. PubMed ID: 26409324 [TBL] [Abstract][Full Text] [Related]
20. Cocaine-induced hepatonephrotoxicity: a case report. Gubbins GP; Schiffman RM; Alapati RS; Batra SK Henry Ford Hosp Med J; 1990; 38(1):55-6. PubMed ID: 2228713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]